Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.292 SEK | -4.26% | +4.10% | -28.34% |
Mar. 26 | Transcript : Vivesto AB - Special Call | |
Mar. 07 | Vivesto AB Doses First Patient in its Clinical Paccal Vet Trial | CI |
Business Summary
Number of employees: 14
Sales per Business
SEK in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100.0
%
| 26 | 100.0 % | 1 | 100.0 % | -96.12% |
Sales per region
SEK in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Other Countries
100.0
%
| - | - | 1 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Erik Kinnman
CEO | Chief Executive Officer | 66 | 23-01-22 |
Robert Maiorana
DFI | Director of Finance/CFO | 64 | 20-11-30 |
Heidi Ramstad
CTO | Chief Tech/Sci/R&D Officer | 55 | 21-02-28 |
Johanna Röstin
LAW | General Counsel | 57 | 21-09-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 44 | 19-03-18 | |
Hege Hellstrom
BRD | Director/Board Member | 59 | 19-09-25 |
Pål Ryfors
BRD | Director/Board Member | 41 | 22-05-24 |
Roger Tell
BRD | Director/Board Member | 59 | 22-05-24 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 538,043,455 | 330,469,658 ( 61.42 %) | 0 | 61.42 % |
Company contact information
Sector
Sales per region
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-25.15% | 15.19M | |
+31.52% | 690B | |
+21.96% | 546B | |
-5.21% | 358B | |
+17.02% | 323B | |
+5.01% | 287B | |
+13.68% | 235B | |
+3.81% | 199B | |
-10.63% | 195B | |
+3.98% | 161B |
- Stock Market
- Equities
- VIVE Stock
- Company Vivesto AB